Related Experiment Videos
Application of irradiation as an immunosuppressive agent
Summary
Total lymphoid irradiation (TLI) effectively induces immunosuppression for organ transplantation. This method, demonstrated in various animal models and human trials, allows for reduced reliance on chemical immunosuppressants, minimizing associated risks.
Area of Science:
- Immunology
- Transplantation Medicine
- Radiation Oncology
Background:
- Total lymphoid irradiation (TLI) demonstrates prolonged immunosuppressive effects, initially observed in Hodgkin's disease treatment.
- Pre-operative TLI has shown immunosuppressive capabilities in allograft recipients, both as a standalone therapy and in combination with chemical agents.
Purpose of the Study:
- To evaluate the efficacy of total lymphoid irradiation (TLI) as an immunosuppressive strategy for organ transplantation.
- To explore the potential of TLI to reduce the dosage of conventional immunosuppressive drugs.
Main Methods:
- Studies involved fractionated TLI combined with allogeneic bone marrow injections in preclinical models (mice, rats, dogs).
- Primate studies utilized TLI and bone marrow injection to assess tolerance of liver and kidney allografts.
- Historical data on sublethal whole-body irradiation for human renal allografts was considered.
Main Results:
- Fractionated TLI and bone marrow injections induced stable chimerism and transplantation tolerance in various animal models.
- TLI in combination with bone marrow injection led to significant tolerance of liver and kidney allografts in primates.
- Clinical experience indicates TLI is a useful immunosuppressant in organ transplantation, enabling lower doses of other immunosuppressive drugs.
Conclusions:
- Total lymphoid irradiation (TLI) is a viable immunosuppressive agent for organ transplantation.
- TLI facilitates transplantation tolerance and allows for a reduction in the dosage of concomitant immunosuppressive therapies.